nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Additional Neurology Topics"

 

FDA Approves First Cannabis-Derived Medication Approved
July 3, 2018   

The US Food and Drug Administration (FDA) has approved the first cannabis-based medicine to treat drug resistant childhood epilepsies...
 Continue reading (Members only)
A Novel Preventive Treatment for Migraine
May 18, 2018   

The first treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide (CGRP), a molecule that is involved in migraine attacks has been FDA-approved...
 Continue reading (Members only)
FDA Advisory Committee Unanimously Supports Approval of Cannabidiol Formulation for Severe Epilepsy
May 1, 2018   

A US FDA Advisory Committee has unanimously voted to support the approval of a plant-based cannabidiol formulation for the adjunct treatment of seizures associated with two severe forms of epilepsy...
 Continue reading
NIH Scientists Watch the Brain’s Lining Heal After Head Injury
April 27, 2018   

In a recent study, Dr. McGavern and colleagues used state-of-the-art imaging tools to watch, in real time the healing process meninges in a mouse model of traumatic brain injury (TBI)...
 Continue reading (Members only)
FDA Warns of Serious Immune System Reaction with Lamotrigine
April 25, 2018   

FDA issues warning that lamotrigine can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system...
 Continue reading
Updated Recommendations For Treatment of Tardive Syndrome
April 20, 2018   

The American Academy of Neurology (AAN) has released updated recommendations for treatment of tardive syndromes...
 Continue reading (Members only)
Pseudobulbar Affect Correlates with Mood Symptoms in Parkinsonian Disorders but not Amyotrophic Lateral Sclerosis
April 2, 2018   

Pseudobulbar affect (PBA) is a psychiatric disorder characterized by inappropriate laughter and crying, independent of mood. PBA is common in amyotrophic lateral sclerosis (ALS) and is becoming...
 Continue reading (Members only)
Mild Traumatic Brain Injury and Aggression, Impulsivity, and History of Other- and Self-Directed Aggression
March 30, 2018   

Mild traumatic brain injury (mTBI) is highly prevalent in the United States, with an estimated 1.3 million reported annually. One of the major consequences of mTBI...
 Continue reading (Members only)
Autism Awareness: Review of Pharmacotherapy for Emotional/Behavioral Symptoms and Potential Future Targets
March 20, 2018   

Autism spectrum disorder (ASD) is a neurodevelopmental disorder typically diagnosed in childhood and characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, and activities. There are no pharmacological agents approved...
 Continue reading
Heart Function May Correlate With Brain Function
November 24, 2017   

Studies have shown that poor cardiac health is associated with a significant increase in the risk for cognitive decline and dementia....
 Continue reading (Members only)
1234
Top of Page